{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:13:29Z","timestamp":1740136409868,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["0301020499QC-W0117"],"award-info":[{"award-number":["0301020499QC-W0117"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10072-024-07856-3","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T14:55:42Z","timestamp":1730300142000},"page":"751-760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dopamine transporter availability based on white matter hyperintensity during early to mid-stage Parkinson\u2019s disease and multiple system atrophy: a case control study"],"prefix":"10.1007","volume":"46","author":[{"given":"Rui","family":"Zuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6601-3208","authenticated-orcid":false,"given":"Hua","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"issue":"4","key":"7856_CR1","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/jnr.24779","volume":"99","author":"M Valli","year":"2021","unstructured":"Valli M, Cho SS, Masellis M, Chen R, Koshimori Y, Diez-Cirarda M et al (2021) <ArticleTitle Language=\u201cEn\u201d>Extra-striatal dopamine in Parkinson\u2019s disease with rapid eye movement sleep behavior disorder. J Neurosci Res 99(4):1177\u20131187","journal-title":"J Neurosci Res"},{"issue":"10","key":"7856_CR2","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager J, Andersen KB, Knudsen K, Skj\u00e6rb\u00e6k C, Fedorova TD, Okkels N et al (2020) Brain-first versus body-first Parkinson\u2019s disease: a multimodal imaging case-control study. Brain 143(10):3077\u20133088","journal-title":"Brain"},{"key":"7856_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.parkreldis.2020.08.010","volume":"79","author":"E Porter","year":"2020","unstructured":"Porter E, Roussakis AA, Lao-Kaim NP, Piccini P (2020) Multimodal dopamine transporter (DAT) imaging and magnetic resonance imaging (MRI) to characterise early Parkinson\u2019s disease. Parkinsonism Relat Disord 79:26\u201333","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"7856_CR4","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.2169\/internalmedicine.2489-18","volume":"58","author":"K Ikeda","year":"2019","unstructured":"Ikeda K, Ebina J, Kawabe K, Iwasaki Y (2019) Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications. Intern Med 58(12):1665\u20131672","journal-title":"Intern Med"},{"issue":"1","key":"7856_CR5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/RLU.0000000000001885","volume":"43","author":"S Tinaz","year":"2018","unstructured":"Tinaz S, Chow C, Kuo PH, Krupinski EA, Blumenfeld H, Louis ED et al (2018) Semiquantitative Analysis of Dopamine Transporter Scans in Patients With Parkinson Disease. Clin Nucl Med 43(1):e1\u2013e7","journal-title":"Clin Nucl Med"},{"key":"7856_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.neurobiolaging.2019.05.004","volume":"80","author":"LJ De Schipper","year":"2019","unstructured":"De Schipper LJ, Hafkemeijer A, Bouts MJRJ, van der Grond J, Marinus J, Henselmans JML et al (2019) Age- and disease-related cerebral white matter changes in patients with Parkinson\u2019s disease. Neurobiol Aging 80:203\u2013209","journal-title":"Neurobiol Aging"},{"key":"7856_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.parkreldis.2019.07.019","volume":"66","author":"SJ Chung","year":"2019","unstructured":"Chung SJ, Lee YH, Yoo HS, Oh JS, Kim JS, Ye BS et al (2019) White matter hyperintensities as a predictor of freezing of gait in Parkinson\u2019s disease. Parkinsonism Relat Disord 66:105\u2013109","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"7856_CR8","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1212\/WNL.0000000000009890","volume":"95","author":"Y Lee","year":"2020","unstructured":"Lee Y, Ko J, Choi YE, Oh JS, Kim JS, Sunwoo MK et al (2020) Areas of white matter hyperintensities and motor symptoms of Parkinson disease. Neurology 95(3):e291\u2013e298","journal-title":"Neurology"},{"issue":"11","key":"7856_CR9","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s11604-021-01152-2","volume":"39","author":"S Shin","year":"2021","unstructured":"Shin S, Jun S, Nam HY (2021) Effect of white matter hyperintensity on dopamine transporter availability of striatum measured by F-18 FP-CIT PET. Jpn J Radiol 39(11):1097\u20131102","journal-title":"Jpn J Radiol"},{"issue":"2","key":"7856_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/acn3.50991","volume":"7","author":"SJ Chung","year":"2020","unstructured":"Chung SJ, Yoo HS, Lee YH, Jung JH, Baik K, Ye BS et al (2020) White matter hyperintensities and risk of levodopa-induced dyskinesia in Parkinson\u2019s disease. Ann Clin Transl Neurol 7(2):229\u2013238","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"7856_CR11","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/mds.28510","volume":"36","author":"SH Jeong","year":"2021","unstructured":"Jeong SH, Lee HS, Jung JH, Baik K, Lee YH, Yoo HS et al (2021) White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson\u2019s Disease. Mov Disord 36(6):1411\u20131419","journal-title":"Mov Disord"},{"issue":"7","key":"7856_CR12","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes MT (2019) Parkinson\u2019s Disease and Parkinsonism. Am J Med 132(7):802\u2013807","journal-title":"Am J Med"},{"issue":"7794","key":"7856_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X et al (2020) Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578(7794):273\u2013277","journal-title":"Nature"},{"key":"7856_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1196\/annals.1379.013","volume":"1097","author":"WM van der Flier","year":"2007","unstructured":"van der Flier WM, Barkhof F, Scheltens P (2007) Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRI. Ann N Y Acad Sci 1097:215\u2013224","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"7856_CR15","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601","journal-title":"Mov Disord"},{"issue":"9","key":"7856_CR16","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670\u2013676","journal-title":"Neurology"},{"key":"7856_CR17","doi-asserted-by":"publisher","first-page":"105159","DOI":"10.1016\/j.archger.2023.105159","volume":"116","author":"H Li","year":"2024","unstructured":"Li H, Cao C, Li Y (2024) Self-directed physical activity interventions for motor symptoms and quality of life in early and mid-stage Parkinson\u2019s disease: A systematic review and meta-analysis. Arch Gerontol Geriatr 116:105159","journal-title":"Arch Gerontol Geriatr"},{"issue":"2","key":"7856_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR Am J Roentgenol 149(2):351\u2013356","journal-title":"AJR Am J Roentgenol"},{"key":"7856_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jns.2017.12.018","volume":"385","author":"H Joki","year":"2018","unstructured":"Joki H, Higashiyama Y, Nakae Y, Kugimoto C, Doi H, Kimura K et al (2018) White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson\u2019s disease with dementia, and Alzheimer\u2019s disease. J Neurol Sci 385:99\u2013104","journal-title":"J Neurol Sci"},{"key":"7856_CR20","doi-asserted-by":"publisher","first-page":"682776","DOI":"10.3389\/fnagi.2021.682776","volume":"13","author":"X Ma","year":"2021","unstructured":"Ma X, Li S, Li C, Wang R, Chen M, Chen H et al (2021) Total Cerebral Small Vessel Score Association With Hoehn and Yahr Stage in Parkinson\u2019s Disease. Front Aging Neurosci 13:682776","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"7856_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41531-021-00214-6","volume":"7","author":"NY Shin","year":"2021","unstructured":"Shin NY, Park YW, Yoo SW, Yoo JY, Choi Y, Jang J et al (2021) Adverse effects of hypertension, supine hypertension, and perivascular space on cognition and motor function in PD. NPJ Parkinsons Dis 7(1):69","journal-title":"NPJ Parkinsons Dis"},{"issue":"12","key":"7856_CR22","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1080\/01616412.2022.2112378","volume":"44","author":"O Sinani","year":"2022","unstructured":"Sinani O, Dadouli K, Ntellas P, Kapsalaki EZ, Vlychou M, Raptis DG et al (2022) Association between white matter lesions and Parkinson\u2019s disease: an impact on Postural\/Gait difficulty phenotype and cognitive performance. Neurol Res 44(12):1122\u20131131","journal-title":"Neurol Res"},{"issue":"8","key":"7856_CR23","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/cells8080872","volume":"8","author":"G Palermo","year":"2019","unstructured":"Palermo G, Ceravolo R (2019) Molecular Imaging of the Dopamine Transporter. Cells 8(8):872","journal-title":"Cells"},{"issue":"4","key":"7856_CR24","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.pneurobio.2011.08.009","volume":"95","author":"DJ Brooks","year":"2011","unstructured":"Brooks DJ, Pavese N (2011) Imaging biomarkers in Parkinson\u2019s disease. Prog Neurobiol 95(4):614\u2013628","journal-title":"Prog Neurobiol"},{"key":"7856_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.parkreldis.2019.10.002","volume":"73","author":"SG Ryman","year":"2020","unstructured":"Ryman SG, Poston KL (2020) MRI biomarkers of motor and non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord 73:85\u201393","journal-title":"Parkinsonism Relat Disord"},{"key":"7856_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.parkreldis.2021.11.033","volume":"94","author":"DG Park","year":"2022","unstructured":"Park DG, Kang SY, Hong JY, Sunwoo MK, Yoon JH (2022) Factors associated with motor severity in vascular parkinsonism with normal dopamine transporter imaging. Parkinsonism Relat Disord 94:99\u2013103","journal-title":"Parkinsonism Relat Disord"},{"key":"7856_CR27","doi-asserted-by":"publisher","first-page":"120011","DOI":"10.1016\/j.jns.2021.120011","volume":"433","author":"M Narasimhan","year":"2022","unstructured":"Narasimhan M, Schwartz R, Halliday G (2022) Parkinsonism and cerebrovascular disease. J Neurol Sci 433:120011","journal-title":"J Neurol Sci"},{"issue":"5","key":"7856_CR28","first-page":"61","volume":"113","author":"J Levin","year":"2016","unstructured":"Levin J, Kurz A, Arzberger T, Giese A, H\u00f6glinger GU (2016) The Differential Diagnosis and Treatment of Atypical Parkinsonism. Dtsch Arztebl Int 113(5):61\u201369","journal-title":"Dtsch Arztebl Int"},{"issue":"9423","key":"7856_CR29","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","volume":"363","author":"A Samii","year":"2004","unstructured":"Samii A, Nutt JG, Ransom BR (2004) Parkinson\u2019s disease. Lancet 363(9423):1783\u20131793","journal-title":"Lancet"},{"key":"7856_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jns.2017.01.042","volume":"375","author":"F Yoshii","year":"2017","unstructured":"Yoshii F, Ryo M, Baba Y, Koide T, Hashimoto J (2017) Combined use of dopamine transporter imaging (DAT-SPECT) and 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson\u2019s disease. J Neurol Sci 375:80\u201385","journal-title":"J Neurol Sci"},{"issue":"6","key":"7856_CR31","first-page":"799","volume":"48","author":"EE Smith","year":"2021","unstructured":"Smith EE, Duchesne S, Gao F, Saad F, Whitehead V, McCreary CR et al (2021) Vascular Contributions to Neurodegeneration: Protocol of the COMPASS-ND Study. Can J Neurol Sci 48(6):799\u2013806","journal-title":"Can J Neurol Sci"},{"issue":"4","key":"7856_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrneurol.2011.21","volume":"7","author":"NI Bohnen","year":"2011","unstructured":"Bohnen NI, Albin RL (2011) White matter lesions in Parkinson disease. Nat Rev Neurol 7(4):229\u2013236","journal-title":"Nat Rev Neurol"},{"key":"7856_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3389\/fnins.2019.00299","volume":"13","author":"X Sun","year":"2019","unstructured":"Sun X, Liu F, Liu Q, Gai Y, Ruan W, Wimalarathne DN et al (2019) Quantitative Research of 11\u00a0C-CFT and 18F-FDG PET in Parkinson\u2019s Disease: A Pilot Study With NeuroQ Software. Front Neurosci 13:299","journal-title":"Front Neurosci"},{"issue":"4","key":"7856_CR34","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/mds.27316","volume":"33","author":"P Fazio","year":"2018","unstructured":"Fazio P, Svenningsson P, Csel\u00e9nyi Z, Halldin C, Farde L, Varrone A (2018) Nigrostriatal dopamine transporter availability in early Parkinson\u2019s disease. Mov Disord 33(4):592\u2013599","journal-title":"Mov Disord"},{"key":"7856_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.sleep.2020.02.012","volume":"70","author":"J Ma\u0161kov\u00e1","year":"2020","unstructured":"Ma\u0161kov\u00e1 J, \u0160koloud\u00edk D, \u0160tofanikov\u00e1 P, Ibarburu V, Kemlink D, Zogala D et al (2020) Comparative study of the substantia nigra echogenicity and 123I-Ioflupane SPECT in patients with synucleinopathies with and without REM sleep behavior disorder. Sleep Med 70:116\u2013123","journal-title":"Sleep Med"},{"key":"7856_CR36","doi-asserted-by":"publisher","first-page":"117481","DOI":"10.1016\/j.jns.2021.117481","volume":"426","author":"A Butt","year":"2021","unstructured":"Butt A, Kamtchum-Tatuene J, Khan K, Shuaib A, Jickling GC, Miyasaki JM et al (2021) White matter hyperintensities in patients with Parkinson\u2019s disease: A systematic review and meta-analysis. J Neurol Sci 426:117481","journal-title":"J Neurol Sci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07856-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07856-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07856-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T09:15:11Z","timestamp":1737969311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07856-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["7856"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07856-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of the First Affiliated Hospital of Chongqing Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have read and approved the content, and agree to submit for consideration for publication in the journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}